Whole Body Health Sale

Migraine Headache References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Rakel: Textbook of Family Medicine, 8th ed. Copyright © 2011 Saunders, An Imprint of Elsevier Available at: http://www.mdconsult.com/books/page.do?sid=1327235022&eid=4-u1.0-B978-1-4377-1160-8..10042-9--s0085&isbn=978-1-4377-1160-8&uniqId=342348469-671 Accessed 6/29/2012
  2. Ferri: Ferri's Clinical Advisor 2013, 1st ed. Copyright © 2012 Mosby, An Imprint of Elsevier Available at: http://www.mdconsult.com/books/page.do?sid=1327231261&eid=4-u1.0-B978-0-323-08373-7..00017-0--sc0025&isbn=978-0-323-08373-7&uniqId=342348469-680#4-u1.0-B978-0-323-08373-7..00017-0--sc0025 Accessed 6/29/2012.
  3. NINDS (National Institute of Neurological Disorders and Stroke). NINDS Migraine Information Page. Available at: http://www.ninds.nih.gov/disorders/migraine/migraine.htm. Last updated March 1, 2012. Accessed July 2, 2012.
  4. Goldman: Goldman's Cecil Medicine, 24th ed. Copyright © 2011 Saunders, An Imprint of Elsevier Available at: http://www.mdconsult.com/books/page.do?sid=1327227253&eid=4-u1.0-B978-1-4377-1604-7..00405-X--s0045&isbn=978-1-4377-1604-7&uniqId=342348469-680#4-u1.0-B978-1-4377-1604-7..00405-X--s0045 Accessed 6/29/2012.
  5. NIH-MedlinePlus. Migraine Availabel at: http://www.nlm.nih.gov/medlineplus/migraine.html Accessed 6/29/2012.
  6. Mayo Clinic. Migraine 6/4/2011. Available at: http://www.mayoclinic.com/health/migraine-headache/DS00120 Accessed: 6/29/2012.
  7. D'Amico D and Tepper SJ. Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat. 2008;4(6):1155-1167.
  8. Univ. of Maryland Medical Center. Migraine headache. Available at: http://www.umm.edu/altmed/articles/migraine-headache-000072.htm Accessed 6/29/2012.
  9. Cutrer F., et al. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. In: UpToDate, Jerry W Swanson, John F Dashe (Eds), UpToDate, Waltham, MA, 2012.
  10. American Academy of Neurology. Ramadan NM. Silberstein SD, Freitag FG, et al. Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management for Prevention of Migraine. Available at: http://www.aan.com/professionals/practice/pdfs/gl0090.pdf Accessed 6/29/2012.
  11. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache. 2011;2:77-83.
  12. Durham PL. CGRP-Receptor Antagonists – A Fresh Approach to Migraine Therapy? N Engl J Med. 2004;350:1073-1075.
  13. Moloney MF, Johnson CJ. Migraine headaches: diagnosis and management. J Midwifery Womens Health. 2011;56(3):282-292.
  14. Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache. 2007;47(3):355-63.
  15. Chaibi A, Tuchin PJ, Russell MB. Manual therapies for migraine: a systematic review. J Headache Pain. 2011;12(2):127-133.
  16. Magis D, Schoenen J. Treatment of migraine: update on new therapies. CurrOpin Neurol. 2011;24(3):203-10.
  17. Rothrock JF. Understanding Migraine: A Tale of Hope and Frustration. Headache: The Journal of Head and Face Pain. 2011;51(7):1188-1190.
  18. Sarchielli P, Mancini ML, Calabresi P. Practical considerations for the treatment of elderly patients with migraine. Drugs Aging. 2006;23(6):461-89.
  19. Shugart C. Management of migraine headache: an overview of current practice. Jaapa. 2012;25(2):48-52.
  20. Dzugan SA. The Migraine Cure. United States Lynn Sonberg Book Associates. ©2006.
  21. Schiapparelli P, Allais G, CastagnoliGabellari I, Rolando S, Terzi MG, Benedetto C. Non-pharmacological approach to migraine prophylaxis: part II. Neurol Sci. 2010;31(1):S137-139.
  22. Rizzoli PB. Talking about migraine. Harvard Health Letter. www.health.hardvard.edu. January 2012.
  23. Walling A. (2012). Chapter 10: The Nervous System: Migrine Headache (pg.621). In Edward T. Bope, Rick D. Kellerman (Ed.), Conn's Current Therapy (1st ed.). Saunders, An Imprint of Elsevier.
  24. Digre K. (2011a). Chapter 405: Headaches and other pain: Migraine Headache (pg. 2247). In Lee Goldman, Andrew I. Schafer (Ed.), Goldman’s Cecil Medicine (24th ed.). Saunders, An Imprint of Elsevier.
  25. Digre K. (2011b). Chapter 405: Headaches and other pain. Migraine Headache (pg. 2247). In Lee Goldman, Andrew I. Schafer (Ed.), Goldman’s Cecil Medicine (24th ed.). Saunders, An Imprint of Elsevier.
  26. Cutrer F., et al. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. In: UpToDate, Jerry W Swanson, John F Dashe (Eds), UpToDate, Waltham, MA, 2012.
  27. Rossi P, Ambrosini A, and Buzzi MG. Prodromes and predictors of migraine attack. Funct Neurol. 2005 Oct-Dec;20(4):185-91.
  28. Cutrer F., et al. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. In: UpToDate, Jerry W Swanson, John F Dashe (Eds), UpToDate, Waltham, MA, 2012.
  29. Digre K. (2011c). Chapter 405: Headaches and other pain. Migraine Headache (pg. 2247). In Lee Goldman, Andrew I. Schafer (Ed.), Goldman’s Cecil Medicine (24th ed.). Saunders, An Imprint of Elsevier.
  30. Bogdanov VB, Multon S, Chauvel V, et al. Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiol Dis. 2011;41(2):430-435.
  31. Cutrer F., et al. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. In: UpToDate, Jerry W Swanson, John F Dashe (Eds), UpToDate, Waltham, MA, 2012.
  32. Charles A. Advances in the basic and clinical science of migraine. Ann Neurol. 2009;65(5):491-498.
  33. Panconesi A. Serotonin and migraine: a reconsideration of the central theory. J Headache Pain. 2008;9(5):267-76.
  34. Gyermek L. Pharmacology of serotonin as related to anesthesia. J ClinAnesth. 1996;8(5):402-425.
  35. Masruha MR, de Souza Vieira DS, Minett TS, et al. Low urinary 6-sulphatoxymelatonin concentrations in acute migraine. J Headache Pain. 2008;9(4):221-224.
  36. Masruha MR, Lin J, de Souza Vieira DS, et al. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities. Headache. 2010 Mar;50(3):413-9. Epub 2008 Oct 8.
  37. Vogler B, Rapoport AM, Tepper SJ, Sheftell F, Bigal ME. Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs. 2006;20(5):343-350.
  38. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007;27(11):1293-300.
  39. Sakai Y, Dobson C, Diksic M, et al. Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology. 2008 Feb 5;70(6):431-9.
  40. Chugani DC, Niimura K, Chaturvedi S, et al. Increased brain serotonin synthesis in migraine. Neurology. 1999 Oct 22;53(7):1473-9.
  41. Dhillon KS, Singh J, and Lyall JS. A new horizon into the pathobiology, etiology and treatment of migraine. Med Hypotheses. 2011 Jul;77(1):147-51.
  42. Sacco S, Ricci S, Degan D, Carolei A. Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain. 2012;13(3):177-189.
  43. Calhoun A. Estrogen-associated migraine. In: UpToDate, Barbieri R., Swanson J. (Eds), UpToDate, Waltham, MA, 2012.
  44. MacGregor EA. Estrogen replacement and migraine. Maturitas. 2009;63(1):51-55.
  45. Lay CL, Broner SW. Migraine in women. NeurolClin. 2009;27(2):503-511.
  46. Dzugan SA. An Innovative New Treatment for Migraine. Life Extension magazine. September, 2004
  47. Thys-Jacobs S. Micronutrients and the pre-menstrual syndrome: the case for calcium. J Am CollNutr. 2000 Apr;19(2):220-7.
  48. Aloisi P, Marrelli A, Porto C, et al. Visual evoked potentials and serum magnesium levels in juvenile migraine patients. Headache. 1997 Jun;37(6):383-5.
  49. Li W, Zheng T, Altura BM, Altura BT. Sex steroid hormones exert biphasic effects on cytosolic magnesium ions in cerebral vascu- lar smooth muscle cells: possible relationships to migraine frequency in premenstrual syndromes and stroke incidence. Brain Res Bull. 2001 Jan 1;54(1):83-9.
  50. Calhoun AH, Hutchinson S. Hormonal therapies for menstrual migraine. Curr Pain Headache Rep. 2009;13(5):381-385.
  51. Holdaway IM, Parr CE, France J. Treatment of a patient with severe menstrual migraine using the depot LHRH analogue Zoladex. Aust N Z J Obstet Gynaecol. 1991;31(2):164-5.
  52. Finocchi C and Ferrari M. Female reproductive steroids and neuronal excitability. Neurol Sci. 2011 May;32Suppl1:S31-5.
  53. Nappi RE, Sances G, Detaddei S, Ornati A, Chiovato L, Polatti F. Hormonal management of migraine at menopause. Menopause Int. 2009;15(2):82-6.
  54. Shuster L, Faubion S, Sood R, Casey P. Hormonal Manipulation Strategies in the Management of Menstrual Migraine and Other Hormonally Related Headaches. Current Neurology and Neuroscience Reports. 2011;11(2):131-138.
  55. Schurks M, Rist PM, Kurth T. Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia. 2010;30(11):1306-1328.
  56. Dzugan SA and Smith RA. The simultaneous restoration of neurohormonal and metabolic integrity as a very promising method of migraine management. Bull Urg Rec Med. 2003;4(4):622-8.
  57. Katsarava Z, Buse DC, Manack AN, Lipton RB. Defining the differences between episodic migraine and chronic migraine. Curr Pain Headache Rep. 2012;16(1):86-92.
  58. NHF (Nation Headache Foundation) Migraine. Accessed 05/22/2012. Available online at: http://www.headaches.org/education/Headache_Topic_Sheets/Migraine. Copyright 2012.
  59. Bope and Kellerman: Conn's Current Therapy 2012, 1st ed. Walling A (ed.) Copyright © 2011 Saunders, An Imprint of Elsevier. Available at: http://www.mdconsult.com/books/page.do?sid=1328661388&eid=4-u1.0-B978-1-4557-0738-6..00010-3--sc0050&isbn=978-1-4557-0738-6&uniqId=343672168-780 Accessed 7/3/2012.
  60. Merck Manual. Migraine. Available at: http://www.merckmanuals.com/professional/neurologic_disorders/headache/migraine.html?qt=migraine&alt=sh#v1040393 Accessed 6/28/2012.
  61. Kwiatkowski T, Alagappan K (eds.) Marx: Rosen's Emergency Medicine, 7th ed. Copyright © 2009 Mosby, An Imprint of Elsevier. Availble at: http://www.mdconsult.com/books/page.do?sid=1328667371&eid=4-u1.0-B978-0-323-05472-0..00101-8&isbn=978-0-323-05472-0&uniqId=343672168-795 Accessed 7/3/2012.
  62. Mayo Clinic. Migraine: Causes. Available at: http://www.mayoclinic.com/health/migraine-headache/ds00120/dsection=causes. Accessed July 2, 2012.
  63. Braun, E., (2010) Chapter 17: Pain Management in the Head and Neck Patient (pg. 247). In: Flint, P. (Ed.), Cummings Otolaryngology: Head & Neck Surgery (5th ed.). Mosby, An Imprint of Elsevier.
  64. Hershey, A., (2011) Chapter 588: Headaches (pg. 2040). In: Kliegman, R. (Ed.), Nelson Textbook of Pediatrics (19th ed.). Saunders, An Imprint of Elsevier.
  65. Bajwa Z., Acute treatment of migraine in adults. In: UpToDate, Swanson J., Dashe J. (Eds), UpToDate, Waltham, MA, 2012.
  66. Aukerman G, Knutson D, and Miser W. Management of the Acute Migraine Headache. Am Fam Physician. 2002 Dec 1;66(11):2123-2131.
  67. Bajwa Z., Acute treatment of migraine in adults. In: UpToDate, Swanson J., Dashe J. (Eds), UpToDate, Waltham, MA, 2012.
  68. Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic M) in the treatment of migraine. Headache. 2011;51(7):1078-1086.
  69. Bajwa Z., Acute treatment of migraine in adults. In: UpToDate, Swanson J., Dashe J. (Eds), UpToDate, Waltham, MA, 2012.
  70. MD Consult. Migraine. Updated 4/22/2011. Available at: http://www.mdconsult.com/das/pdxmd/body/344049714-3/0?type=med&eid=9-u1.0-_1_mt_1017198#Contributors Accessed 7/5/2012.
  71. Aukerman G, Knutson D, and Miser W. Management of the Acute Migraine Headache. Am Fam Physician. 2002 Dec 1;66(11):2123-2131.
  72. Braun, E., (2010) Chapter 17: Pain Management in the Head and Neck Patient (pg. 246). In: Flint, P. (Ed.), Cummings Otolaryngology: Head & Neck Surgery (5th ed.). Mosby, An Imprint of Elsevier.
  73. Bajwa Z., Preventive treatment of migraine in adults. In: UpToDate, Swanson J., Dashe J. (Eds), UpToDate, Waltham, MA, 2010.
  74. Garza I., Medication overuse headache: Treatment and prognosis. In: UpToDate, Swanson J., Dashe J. (Eds), UpToDate, Waltham, MA, 2012.
  75. Young WB. Medication Overuse Headache. Curr Treat Options Neurol. 2001 Mar;3(2):181-188.
  76. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446-452.
  77. Chaibi A, Tuchin PJ, Russell MB. Manual therapies for migraine: a systematic review. J Headache Pain. 2011;12(2):127-133.
  78. Gallagher, M., (2012) Chapter 1: Symptomatic Care Pending Diagnosis (pg. 1). In: Bope, E. (Ed.), Conn's Current Therapy 2012 (1st ed.). Saunders, An Imprint of Elsevier.
  79. Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev. 2009;21(1).
  80. Honaker J, Samy RN. Migraine-associated vestibulopathy. CurrOpinOtolaryngol Head Neck Surg. 2008;16(5):412-5.
  81. Hauge AS, Kirchmann M, and Olesen J. Characterization of consistent triggers of migraine with aura. Cephalalgia. 2011 Mar;31(4):416-38.
  82. Mueller LL. Diagnosing and managing migraine headache. J Am Osteopath Assoc. 2007;107(10 Suppl 6):ES10-16.
  83. Ross SM. Clinical applications of integrative therapies for prevention and treatment of migraine headaches. Holist NursPract. 2011;25(1):49-52.
  84. Mueller LL. Diagnosing and managing migraine headache. J Am Osteopath Assoc. 2007;107(10 Suppl 6):ES10-16.
  85. Gallagher, M., (2012) Chapter 1: Symptomatic Care Pending Diagnosis (pg. 1). In: Bope, E. (Ed.), Conn's Current Therapy 2012 (1st ed.). Saunders, An Imprint of Elsevier.
  86. Mueller LL. Diagnosing and managing migraine headache. J Am Osteopath Assoc. 2007;107(10 Suppl 6):ES10-16.
  87. Ross SM. Clinical applications of integrative therapies for prevention and treatment of migraine headaches. Holist NursPract. 2011;25(1):49-52.
  88. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446-452.
  89. Arroyave Hernandez CM, Echavarría Pinto M, and Hernández Montiel HL. Food allergy mediated by IgG antibodies associated with migraine in adults. Rev Alerg Mex. 2007 Sep-Oct;54(5):162-8.
  90. Mylek D. [Migraine as one of the symptoms of food allergy]. Pol TygLek. 1992 Jan 20-27;47(3-4):89-91.
  91. Gallagher, M., (2012) Chapter 1: Symptomatic Care Pending Diagnosis (pg. 1). In: Bope, E. (Ed.), Conn's Current Therapy 2012 (1st ed.). Saunders, An Imprint of Elsevier.
  92. Fukui PT, GonçalvesTR, Strabelli CG, et al. Trigger factors in migraine patients. Arq Neuropsiquiatr. 2008;66(3A):494-9.
  93. O'Brien HL, Hershey AD. Vitamins and paediatric migraine: Riboflavin as a preventative medication: Cephalalgia. 2010 Dec;30(12):1417-8. Epub 2010 Jul 27.
  94. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005;45(3):196-203.
  95. Oelkers-Ax R, Leins A, Parzer P, et al. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain. 2008;12(3):301-13.
  96. Diener HC, Rahlfs VW, Danesch U. The First Placebo-Controlled Trial of a Special Butterbur Root Extract for the Prevention of Migraine: Reanalysis of Efficacy Criteria. European Neurology. 2004;51(2):89-97.
  97. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasiteshybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63(12):2240-2244.
  98. Holland S, Silberstein SD, Freitag F, DodickDW, Argoff C, Ashman E. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1346-53
  99. Ross SM. Coenzyme q10: ubiquinone: a potent antioxidant and key energy facilitator for the heart. Holist NursPract. 2007;21(4):213-214.
  100. Ross SM. Clinical applications of integrative therapies for prevention and treatment of migraine headaches. Holist NursPract. 2011;25(1):49-52.
  101. Slater SK, Nelson TD, Kabbouche MA, et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzymeQ10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011;31(8):897-905.
  102. AMR (Alternative Medicine Review) Riboflavin. Monograph. Altern Med Rev. 2008;13(4):334-340.
  103. Condo M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain. 2009;10(5):361-365.
  104. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhaupl KM, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11(7):475-477.
  105. Brenner SR. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs: Neurology. 2010 Jan 12;74(2):182-3; author reply 183.
  106. DiLorenzo C, Pierelli F, Coppola G, Grieco G, Rengo C. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology 2009;72:1588–1594.
  107. Goodyear-Smith F. Feverfew. Bachelor's buttons, Featherfew (Tanacetumparthenium L. aka Chrysanthemum parthenium L. aka Pyrethrum parthenium L.). J Prim Health Care. 2010;2(4):337.
  108. Saranitzky E, White CM, Baker EL, Baker WL, Coleman CI. Feverfew for migraine prophylaxis: a systematic review. J Diet Suppl. 2009;6(2):91-103.
  109. Chen CF, Leung AY. Gene response of human monocytic cells for the detection of antimigraine activity of feverfew extracts. Can J PhysiolPharmacol. 2007;85(11):1108-1115.
  110. Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004;(1):CD002286.
  111. Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic M) in the treatment of migraine. Headache. 2011;51(7):1078-1086.
  112. Ernst E, Pittler MH. The efficacy and safety of feverfew (Tanacetumparthenium L.): an update of a systematic review. Public Health Nutr. 2000;3(4A):509-514.
  113. Pareek, A, Suthar M, Rathore G, et al. Feverfew (Tanacetumparthenium L.): A systematic review. Pharmacogn Rev. 2011 Jan-Jun; 5(9): 103–110.
  114. Qujeq D, Zandemami M, Ahanger AA, Shahabadin ME. Evaluation of intracellular magnesium and calcium concentration in patients with migraine. Neurosciences. 2012;17(1):85-86.
  115. Talebi M, Savadi-Oskouei D, Farhoudi M, et al. Relation between serum magnesium level and migraine attacks. Neurosciences. 2011;16(4):320-323.
  116. Sun-Edelstein C, Mauskop A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009;9(3):369-379.
  117. Koseoglu E, Talaslioglu A, Gonul AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnes Res. 2008;21(2):101-108.
  118. Esposito M, Carotenuto M. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci. 2011;32(1):79-81.
  119. Slutsky I, umaria N, Wu LJ, et al. Neuron. 2010 Jan 28;65(2):165-77. Enhancement of learning and memory by elevating brain magnesium. Neuron. 2010 Jan 28;65(2):165-77.
  120. Wilhelmsen M, Amirian I, Reiter RJ, Rosenberg J, Gögenur I. Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. Journal of Pineal Research. 2011;51(3):270-277.
  121. Masruha MR, Lin J, de Souza Vieira DS, et al. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities. Headache. 2010;50(3):413-419.
  122. Gagnier JJ. The therapeutic potential of melatonin in migraines and other headache types. Altern Med Rev. 2001;6(4):383-389.
  123. Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI. Prophylaxis of migraine with melatonin: a randomized controlled trial. Neurology. 2010;75(17):1527-1532.
  124. Peres M. Melatonin for Migraine Prevention. Current Pain and Headache Reports. 2011;15(5):334-335.
  125. De Silva V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology. 2010;49(6):1063-1068.
  126. Carpenter DJ. St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit? Altern Med Rev. 2011;16(1):17-39.
  127. Gatto G, Caleri D, Michelacci S, Sicuteri F. Analgesizing effect of a methyl donor (S-adenosylmethionine) in migraine: an open clinical trial. Int J ClinPharmacol Res. 1986;6(1):15-17.
  128. Fetrow CW, Avila JR. Efficacy of the dietary supplement S-adenosyl-L-methionine. Ann Pharmacother. 2001;35(11):1414-1425.
  129. Sicuteri F. The ingestion of serotonin precursors (L-5-hydroxytryptophan and L-tryptophan) improves migraine headache. Headache. 1973 Apr;13(1):19-22.
  130. Drummond PD. Tryptophan depletion increases nausea, headache and photophobia in migraine sufferers. Cephalalgia. 2006 Oct;26(10):1225-33.
  131. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009;25(5):446-452.
  132. Ross SM. Clinical applications of integrative therapies for prevention and treatment of migraine headaches. Holist NursPract. 2011;25(1):49-52.
  133. Mustafa T, Srivastava KC. Ginger (Zingiberofficinale) in migraine headacheJEthnopharmacol. 1990 Jul;29(3):267-73.